Trial · NCT01842841
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hypoacusis | Ear and labyrinth disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 2 |
| other | Retinal detachment | Eye disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 2 |
| other | Vitreous opacities | Eye disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 2 |
| other | Abdominal pain | Gastrointestinal disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Abdominal pain upper | Gastrointestinal disorders | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 2 |
| other | Constipation | Gastrointestinal disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Enteritis | Gastrointestinal disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Chest pain | General disorders | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Adenoiditis | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Gastroenteritis | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 2 |
| other | Hordeolum | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 2 |
| other | Nasopharyngitis | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 7 |
| other | Otitis media acute | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Subcutaneous abscess | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Upper respiratory tract infection | Infections and infestations | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Concussion | Injury, poisoning and procedural complications | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Contusion | Injury, poisoning and procedural complications | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 3 |
| other | Excoriation | Injury, poisoning and procedural complications | Velaglucerase Alfa (VPRIV®) | 2 | 5 | 2 |
| other | Fall | Injury, poisoning and procedural complications | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
| other | Heat stroke | Injury, poisoning and procedural complications | Velaglucerase Alfa (VPRIV®) | 1 | 5 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01842841/events